Observational Study Links Hormone Therapy Near Menopause to Lower Cardiovascular Risk

A new analysis from the Study of Women's Health Across the Nation (SWAN) indicates that women initiating hormone therapy during peri- or early postmenopause may experience a 22% reduction in cardiovascular disease risk. This observational finding provides valuable information for discussions between patients and healthcare providers regarding the potential benefits and risks of hormone therapy.